Logo

Impavido-miltefosine @Impavido_

FDA-approved for 3 forms of leishmaniasis in patients 12 years and older. Orphan designation: PAM, GAE, amebic karatitis, and more https://t.co/30LJaYTyQ8 Joined September 2017
  • Tweets
    84
  • Followers
    39
  • Following
    387
  • Likes
    63